Beijing, China

Li Kang

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Cygnus Biosciences (Beijing) Co., Ltd.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Kang. Retrieved from https://idiyas.com/inventor/li-kang-dkm52lr1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Li Kang

Introduction

Li Kang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biological sequencing. With a total of 3 patents, his work focuses on improving the accuracy and efficiency of sequencing biological molecules.

Latest Patents

Li Kang's latest patents include methods for obtaining and correcting biological sequence information. These methods involve sequencing biological molecules, such as nucleic acids, and detecting or correcting sequencing errors in the results. Additionally, he has developed kits and systems based on these innovative methods, which enhance the reliability of biological sequencing.

Career Highlights

Throughout his career, Li Kang has worked with notable companies, including Cygnus Biosciences (Beijing) Co., Ltd. and Cygnus Biosciences Co. Ltd. His expertise in biological sequencing has positioned him as a key figure in the industry.

Collaborations

Li Kang has collaborated with several professionals in his field, including Zitian Chen and Wenxiong Zhou. These collaborations have furthered his research and development efforts in biological sequencing technologies.

Conclusion

Li Kang's contributions to biological sequencing through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in biological research and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…